VI
VIS.F Viscofan
- Market cap
- EUR 2.51B
- P/E
- 15.6x
- P/B
- 2.70x
- ROE
- 16.0%
- Dividend yield
- 2.04%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is VIS.F undervalued?
Graham numberVIS.F trades 36.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Viscofan fundamental analysis
No fundamental analysis for Viscofan yet.
Viscofan stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provides collagen casings for processed and pre-cooked fried sausages, and dry-cured sn…
Full company profileViscofan financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Viscofan annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 731M | 778M | 786M | 850M | 912M | 969M | 1.20B | 1.23B | 1.20B | 1.25B | 1.29B |
| Gross Profit | 528M | 567M | 559M | 578M | 640M | 686M | 812M | 805M | 814M | 843M | 866M |
| Operating Income | 149M | 155M | 141M | 123M | 163M | 177M | 191M | 185M | 202M | 204M | 191M |
| EBITDA | - | 203M | 211M | 202M | 232M | 250M | 263M | 260M | 301M | 271M | 285M |
| Net Income | 125M | 122M | 124M | 106M | 123M | 133M | 139M | 141M | 157M | 160M | 149M |
| EPS | - | 2.62 | 2.66 | 2.28 | 2.64 | 2.87 | 3.02 | 3.05 | 3.43 | 3.48 | 3.29 |
| Balance Sheet | |||||||||||
| Total Assets | 931M | 961M | 1.03B | 1.09B | 1.04B | 1.17B | 1.34B | 1.41B | 1.40B | 1.44B | 1.54B |
| Total Liabilities | 223M | 233M | 276M | 301M | 304M | 346M | 438M | 450M | 464M | 509M | 605M |
| Shareholders' Equity | 708M | 728M | 758M | 784M | 736M | 823M | 907M | 958M | 937M | 928M | 933M |
| Cash & Short-term Investments | 45.1M | 28.1M | 31.1M | 51.4M | 52.0M | 91.4M | 51.2M | 52.0M | 55.1M | 62.8M | 73.8M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 141M | 157M | 125M | 178M | 178M | 221M | 121M | 146M | 236M | 195M | - |
| Capital Expenditure | 80.7M | 112M | 71.9M | 62.8M | 55.3M | 95.8M | 116M | 77.1M | 75.0M | 80.4M | 0.00 |
| Free Cash Flow | - | 45.7M | 53.3M | 115M | 123M | 126M | 5.16M | 68.6M | 161M | 115M | - |
| Ratios | |||||||||||
| ROE | 17.7% | 16.8% | 16.3% | 13.5% | 16.6% | 16.2% | 15.4% | 14.7% | 16.8% | 17.2% | 16.0% |
| ROA | 13.4% | 12.7% | 12.0% | 9.7% | 11.8% | 11.4% | 10.4% | 10.0% | 11.2% | 11.1% | 9.7% |
| Net Profit Margin | 17.1% | 15.7% | 15.8% | 12.4% | 13.4% | 13.7% | 11.6% | 11.5% | 13.0% | 12.8% | 11.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Viscofan dividends
- Dividend yield
- 2.04%
- Forward dividend
- 3.28 EUR
- Payout ratio
- 32.0%
- Ex-dividend date
- Nov 25, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 51.1M | 1.11 | 32.0% |
| 2024 | EUR 60.1M | 1.31 | 38.3% |
| 2023 | EUR 89.5M | 1.94 | 63.5% |
| 2022 | EUR 84.5M | 1.83 | 60.6% |
| 2021 | EUR 78.3M | 1.69 | 58.9% |
| 2020 | EUR 109M | 2.36 | 89.3% |
| 2019 | EUR 74.3M | 1.60 | 70.4% |
| 2018 | EUR 72.6M | 1.56 | 58.6% |
| 2017 | EUR 69.4M | 1.49 | 56.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Viscofan
- Insiders 13.57%
- Institutions 39.46%
- Public & others 46.97%
- Shares outstanding 45.1M
- Free float 34.1M
Viscofan company profile
- Company name
- Viscofan
- Ticker
- VIS.F
- ISIN
- ES0184262212
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Cyclical
- Industry
- Containers & Packaging
- Employees
- 5,974
- Fiscal year end
- December
- Address
- PolIgono Industrial Berroa, Tajonar, Spain, 31192
- Phone
- 34 948 19 84 44
- Website
- viscofan.com
About Viscofan
Viscofan, S.A., together with its subsidiaries, manufactures, produces, and distributes casings in Spain, Rest of Europe, Middle East, Africa, Pacific Asia, North America, South America, and internationally. The company offers cellulose, collagen, fibrous, functional solutions, plastics, viscofan veggie, efan, edileaf, nutra-pharma collinstant, nutra-pharma satiscoll, and medical. It also provides collagen casings for processed and pre-cooked fried sausages, and dry-cured snacks, as well as collagen film cover for meat products under the Total Control Net brand. In addition, it offers fibrous casings under the TITANIUM LINE brand. Viscofan, S.A. was incorporated in 1975 and is based in Tajonar, Spain.
Viscofan management
10- Mr. Jose Antonio Canales GarciaCEO, General MD & Executive Director
- Ms. María Del Carmen Peña RuizChief Financial Officer
- Mr. Jesus Calavia CollazosChief Operating Officer
- Mr. José Ignacio Recalde IrurzunChief Technology & Diversification Officer
- Mr. Armando Ares MateosDirector of Investor Relations, Communications & Sustainability
- Mr. José Antonio Cortajarena ManchadoChief Legal Officer & Secretary
- Ms. Beatriz SesmaHuman Resources Director
- Mr. Ricardo Royo RuizChief Europe Business Officer
- Mr. Andrés Díaz EchevarríaManaging Director, EMEA
- Mr. Gabriel Larrea LalagunaChief Supply Chain Officer